Status:
COMPLETED
Monkeypox, Biology, Outcome, Transmission and Epidemiology -Prospective Follow-up of High-risk Contacts
Lead Sponsor:
Institute of Tropical Medicine, Belgium
Collaborating Sponsors:
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Mpox
Eligibility:
All Genders
Brief Summary
With the MBOTE-CONTACT study, a detailed follow-up study of high-risk contacts of mpox patients will be done. The MBOTE-CONTACT study will be nested in the NIH-Funded PALM-007 clinical trial (NCT05559...
Eligibility Criteria
Inclusion
- ▪ Be a high-risk contact of a laboratory-confirmed mpox case, with high-risk defined as having at least one the following types of exposure:
- living in the same household as an mpox patient
- having had sexual contact or intercourse with an mpox patient
- sleeping in the same room as an mpox patient
- sharing a meal with an mpox patient
- children: having played together
- Last exposure to the mpox index case of less than 14 days ago
- Patients of any age and gender (children aged \< 10 years are excluded from venous blood sampling)
- Patient or culturally acceptable representative is willing and able to give informed consent for participation in the study
Exclusion
- Having previously been diagnosed with mpox in the last 3 months
- Inability or unwillingness to comply with the proposed follow-up schedule
Key Trial Info
Start Date :
May 22 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2024
Estimated Enrollment :
257 Patients enrolled
Trial Details
Trial ID
NCT06136117
Start Date
May 22 2023
End Date
October 1 2024
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tunda
Tunda, Maniema Province, Democratic Republic of the Congo